Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 2 completed trials

    Completion Rate
    100%(2/2)
    Active Trials
    0(0%)
    Results Posted
    0%(0 trials)

    Phase Distribution

    Phase 4
    2
    67%
    Phase 3
    1
    33%

    Phase Distribution

    0

    Early Stage

    0

    Mid Stage

    3

    Late Stage

    Phase Distribution3 total trials
    Phase 3Large-scale testing
    1(33.3%)
    Phase 4Post-market surveillance
    2(66.7%)

    Highest Phase Reached

    Phase 4

    Trial Status & Enrollment

    Completion Rate

    100.0%

    2 of 2 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    3

    all time

    Status Distribution
    Completed(2)
    Other(1)

    Detailed Status

    Completed2
    unknown1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    3
    Active
    0
    Success Rate
    100.0%
    Most Advanced
    Phase 4

    Trials by Phase

    Phase 31 (33.3%)
    Phase 42 (66.7%)

    Trials by Status

    unknown133%
    completed267%

    Recent Activity

    0 active trials
    Showing 3 of 3
    unknownphase_4

    Efficacy and Safety of Latanoprost/Timolol for Primary Open Angle Glaucoma

    NCT04098861
    completedphase_4

    Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG)

    NCT00913029
    completedphase_3

    Comparison of the Effects of Bimatoprost and a Fixed Combination of Latanoprost and Timolol on 24-hour Blood and Ocular Perfusion Pressures

    NCT02154217

    Clinical Trials (3)

    Showing 3 of 3 trials
    NCT04098861Phase 4

    Efficacy and Safety of Latanoprost/Timolol for Primary Open Angle Glaucoma

    Unknown
    NCT00913029Phase 4

    Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG)

    Completed
    NCT02154217Phase 3

    Comparison of the Effects of Bimatoprost and a Fixed Combination of Latanoprost and Timolol on 24-hour Blood and Ocular Perfusion Pressures

    Completed

    All 3 trials loaded

    Drug Details

    Intervention Type
    Drug
    Total Trials
    3